Endothelin Receptor Antagonist

DRUG2 trials

Sponsors

Radboud University Medical Center, Liverpool University Hospitals NHS Foundation Trust

Conditions

Angina Pectoris With Normal Coronary ArteriogramCoronary Microvascular Dysfunction (CMD)Coronary SpasmMicrovascular Angina

Phase 2

Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm

Enrolling by invitationNCT06432452

Radboud University Medical CenterCoronary Spasm

Start: 2024-11-11End: 2026-07-01Target: 100Updated: 2024-11-18

Unknown Phase

Endothelin Role In COronary Microcirculation

Active, not recruitingNCT07670091

Liverpool University Hospitals NHS Foundation TrustAngina Pectoris With Normal Coronary Arteriogram, Coronary Microvascular Dysfunction (CMD), Microvascular Angina

Start: 2023-07-01End: 2026-08-01Target: 45Updated: 2026-06-26

Related Papers

Design and rationale of the efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled trial (EDIT-CAS).

2025-04-22